| Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach HJWL Aerts, ER Velazquez, RTH Leijenaar, C Parmar, P Grossmann, ... Nature communications 5 (1), 4006, 2014 | 5219 | 2014 |
| Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ... Journal of the National Cancer Institute 98 (4), 262-272, 2006 | 2375 | 2006 |
| Similarity network fusion for aggregating data types on a genomic scale B Wang, AM Mezlini, F Demir, M Fiume, Z Tu, M Brudno, B Haibe-Kains, ... Nature methods 11 (3), 333-337, 2014 | 1952 | 2014 |
| CD4+ follicular helper T cell infiltration predicts breast cancer survival C Gu-Trantien, S Loi, S Garaud, C Equeter, M Libin, A De Wind, M Ravoet, ... The Journal of clinical investigation 123 (7), 2873-2892, 2013 | 1121 | 2013 |
| Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ... Clinical cancer research 13 (11), 3207-3214, 2007 | 1102 | 2007 |
| Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures P Wirapati, C Sotiriou, S Kunkel, P Farmer, S Pradervand, B Haibe-Kains, ... Breast Cancer Research 10, 1-11, 2008 | 1060 | 2008 |
| Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes C Desmedt, B Haibe-Kains, P Wirapati, M Buyse, D Larsimont, ... Clinical cancer research 14 (16), 5158-5165, 2008 | 964 | 2008 |
| Definition of clinically distinct molecular subtypes in estrogen receptor–positive breast carcinomas through genomic grade S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ... Journal of clinical oncology 25 (10), 1239-1246, 2007 | 953 | 2007 |
| CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma TP Coroller, P Grossmann, Y Hou, ER Velazquez, RTH Leijenaar, ... Radiotherapy and Oncology 114 (3), 345-350, 2015 | 797 | 2015 |
| Robust radiomics feature quantification using semiautomatic volumetric segmentation C Parmar, E Rios Velazquez, R Leijenaar, M Jermoumi, S Carvalho, ... PloS one 9 (7), e102107, 2014 | 666 | 2014 |
| Inconsistency in large pharmacogenomic studies B Haibe-Kains, N El-Hachem, NJ Birkbak, AC Jin, AH Beck, HJWL Aerts, ... Nature 504 (7480), 389-393, 2013 | 580 | 2013 |
| CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer S Loi, S Pommey, B Haibe-Kains, PA Beavis, PK Darcy, MJ Smyth, ... Proceedings of the National Academy of Sciences 110 (27), 11091-11096, 2013 | 558 | 2013 |
| Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution M Chan-Seng-Yue, JC Kim, GW Wilson, K Ng, EF Figueroa, GM O’Kane, ... Nature genetics 52 (2), 231-240, 2020 | 543 | 2020 |
| Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer C Parmar, RTH Leijenaar, P Grossmann, E Rios Velazquez, J Bussink, ... Scientific reports 5 (1), 11044, 2015 | 504 | 2015 |
| survcomp: an R/Bioconductor package for performance assessment and comparison of survival models MS Schröder, AC Culhane, J Quackenbush, B Haibe-Kains Bioinformatics 27 (22), 3206-3208, 2011 | 446 | 2011 |
| Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling HA Azim Jr, S Michiels, PL Bedard, SK Singhal, C Criscitiello, M Ignatiadis, ... Clinical cancer research 18 (5), 1341-1351, 2012 | 445 | 2012 |
| Predicting prognosis using molecular profiling in estrogen receptor-positive breast cancer treated with tamoxifen S Loi, B Haibe-Kains, C Desmedt, P Wirapati, F Lallemand, AM Tutt, ... BMC genomics 9, 1-12, 2008 | 430 | 2008 |
| Transparency and reproducibility in artificial intelligence B Haibe-Kains, GA Adam, A Hosny, F Khodakarami, ... Nature 586 (7829), E14-E16, 2020 | 417 | 2020 |
| PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor–positive breast cancer S Loi, B Haibe-Kains, S Majjaj, F Lallemand, V Durbecq, D Larsimont, ... Proceedings of the National Academy of Sciences 107 (22), 10208-10213, 2010 | 417 | 2010 |
| Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer Y Li, L Zou, Q Li, B Haibe-Kains, R Tian, Y Li, C Desmedt, C Sotiriou, ... Nature medicine 16 (2), 214-218, 2010 | 405 | 2010 |
Christos SotiriouUniversité Libre de Bruxellesbordet.be의 이메일 확인됨